Relationship between clinical characteristics and survival of gastroenteropancreatic neuroendocrine neoplasms: A single-institution analysis (1995–2012) in South China
作者： Yu-hong Wang , Yuan Lin , Ling Xue , Jin-hui Wang , Min-hu Chen
关键词:
摘要: Background Gastroenteropancreatic neuroendocrine neoplasm (GEP-NEN) is the most common type of tumors accounting for 65–75% neoplasms (NENs). Given fact that there are few studies on GEP-NENs among Chinese patients, we performed a retrospective study in South China.
biomedcentral.com
springer.com
sci-hub.se 参考文章(50)
Anna Fen-Yau Li, Chih-Yi Hsu, Alice Li, Ling-Chen Tai, Wen-Yih Liang, Win-Yin Li, Shyh-Haw Tsay, Jeou-Yuan Chen, A 35-year retrospective study of carcinoid tumors in Taiwan: differences in distribution with a high probability of associated second primary malignancies. Cancer. ,vol. 112, pp. 274- 283 ,(2008) , 10.1002/CNCR.23159
Fred T Bosman, Fatima Carneiro, Ralph H Hruban, Neil D Theise, WHO Classification of Tumours of the Digestive System WHO classification of tumours of the digestive system.. ,(2010)
Taekyu LIM, Jeeyun LEE, Jae J KIM, Jong Kyun LEE, Kyu Taek LEE, Young Ho KIM, Kwang-Won KIM, Sung KIM, Tae Sung SOHN, Dong Wook CHOI, Seong Ho CHOI, Ho-Kyung CHUN, Woo Young LEE, Kyoung-Mee KIM, Kee-Taek JANG, Young Suk PARK, Gastroenteropancreatic neuroendocrine tumors: incidence and treatment outcome in a single institution in Korea. Asia-pacific Journal of Clinical Oncology. ,vol. 7, pp. 293- 299 ,(2011) , 10.1111/J.1743-7563.2011.01423.X
T. Konishi, T. Watanabe, J. Kishimoto, K. Kotake, T. Muto, H. Nagawa, , Prognosis and risk factors of metastasis in colorectal carcinoids: results of a nationwide registry over 15 years Gut. ,vol. 56, pp. 863- 868 ,(2007) , 10.1136/GUT.2006.109157
Marie-Louise H. Fj�llskog, Dan. P. K. Granberg, Staffan L. V. Welin, Christopher Eriksson, Kjell E. �berg, Eva T. Janson, Barbro K. Eriksson, Treatment with cisplatin and etoposide in patients with neuroendocrine tumors. Cancer. ,vol. 92, pp. 1101- 1107 ,(2001) , 10.1002/1097-0142(20010901)92:5<1101::AID-CNCR1426>3.0.CO;2-V
Melinda A. Maggard, Jessica B. O??Connell, Clifford Y. Ko, Updated population-based review of carcinoid tumors. Annals of Surgery. ,vol. 240, pp. 117- 122 ,(2004) , 10.1097/01.SLA.0000129342.67174.67
T. Karashima, R-Z. Cai, A.V. Schally, Effects of highly potent octapeptide analogs of somatostatin on growth hormone, insulin and glucagon release Life Sciences. ,vol. 41, pp. 1011- 1019 ,(1987) , 10.1016/0024-3205(87)90690-4
Irvin M. Modlin, Kevin D. Lye, Mark Kidd, A 5‐decade analysis of 13,715 carcinoid tumors Cancer. ,vol. 97, pp. 934- 959 ,(2003) , 10.1002/CNCR.11105
E Mitry, E Baudin, M Ducreux, J-C Sabourin, P Rufié, T Aparicio, P Lasser, D Elias, P Duvillard, M Schlumberger, P Rougier, Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin British Journal of Cancer. ,vol. 81, pp. 1351- 1355 ,(1999) , 10.1038/SJ.BJC.6690325
David S. Klimstra, Irvin R. Modlin, N. Volkan Adsay, Runjan Chetty, Vikram Deshpande, Mithat Gönen, Robert T. Jensen, Mark Kidd, Matthew H. Kulke, Ricardo V. Lloyd, Cesar Moran, Steven F. Moss, Kjell Oberg, Dermot OʼToole, Guido Rindi, Marie E. Robert, Saul Suster, Laura H. Tang, Chin-Yuan Tzen, Mary Kay Washington, Betram Wiedenmann, James Yao, Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set The American Journal of Surgical Pathology. ,vol. 34, pp. 300- 313 ,(2010) , 10.1097/PAS.0B013E3181CE1447